Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
Klotho Neurosciences, Inc. (KLTO)
Company Research
Source: PR Newswire
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative diseases, announces CEO and Chairman Dr. Joseph Sinkule will attend the Inaugural Klotho Conference & Scientific Seminar. The event, the first ever conference on the future of klotho-based therapies and diagnostics, will be held at the UC-Irvine Beal Applied Innovation Center in Irvine, Calif. September 15-16, 2025.The Company's two key scientific advisors and inventors, Dr. Miguel Chillon and Dr. Assumpcio Bosch will be presenting their research achievements exploring Klotho gene therapy in the treatment of ALS, Alzheimer's and longevity.Dr. Sinkule will be available to meet with investors and potential partners during the conference. Interested parties can contact ir@klothoneuro.com. About Klotho Neurosciences, Inc.Klotho Neurosciences, Inc. (NASDAQ: KLTO) is a biogenetics company focused on t
Show less
Read more
Impact Snapshot
Event Time:
KLTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLTO alerts
High impacting Klotho Neurosciences, Inc. news events
Weekly update
A roundup of the hottest topics
KLTO
News
- Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' AwardPR Newswire
- Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in BostonPR Newswire
- Klotho Neurosciences Announces Expiration of Letter of Intent [Yahoo! Finance]Yahoo! Finance
- Klotho Neurosciences Announces Expiration of Letter of IntentPR Newswire
- Klotho to acquire Turn Biotechnologies' assets [Yahoo! Finance]Yahoo! Finance
KLTO
Sec Filings
- 12/5/25 - Form S-1
- 11/13/25 - Form 10-Q
- 11/6/25 - Form S-8
- KLTO's page on the SEC website